Spoil-1 protein and nucleic acid molecules and uses therefor

Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Using tissue cell culture to make a protein or polypeptide

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S071100, C435S320100, C435S325000, C435S455000, C536S024300, C536S023500

Reexamination Certificate

active

06197551

ABSTRACT:

BACKGROUND OF THE INVENTION
Interleukin-1 (IL-1) is a multifunctional cytokine which comprises a family of two polypeptides, IL-1&agr; and IL-1&bgr;, with a wide spectrum of activities. IL-1&agr; and IL-1 &bgr; have been found to possess inflammatory, metabolic, physiologic, hematopoeitic and immunologic properties. Although both forms of IL-1 are distinct gene products, they recognize the same cell surface receptors (i.e. IL-1 receptors, IL-1RtI and IL-1RtII).
Besides skin keratinocytes, some epithelial cells and certain cells in the central nervous system, significant amounts of mRNA encoding IL-1 are not observed in most other healthy cells. However, IL-1 production is dramatically increased by a variety of cells in response to infection, microbial toxins, inflammatory agents, products of activated lymphocytes, complement and clotting components. In addition, IL-1 has been recognized as a prototype of proinflammatory cytokines in that it induces the expression of a variety of genes and the synthesis of several proteins that in turn, induce acute and chronic inflammation. Thus, circulating IL-1 has been implicated in various disease states including sepsis, rheumatoid arthritis, stroke and diabetes. Dinarello (1991) Blood 77(8):1627-1652.
In addition, IL-1 has been shown to regulate bone reabsorption and bone formation with its major activity in bone metabolism being osteoclast activation. See Gowen et al. (1983)
Nature
306:378-380. In fact, IL-1 has been reported to be a potent stimulator of bone reabsorption and has also been reported to increase prostaglandin synthesis in bone. Lorenzo et al. (1987)
Endocrinology
121:1164-1170.
A natural occurring inhibitor of IL-1 which specifically inhibits IL-1 activity has also been identified. Carter et al. (1990)
Nature
344:633. This protein, called IL-1 receptor antagonist protein (IL-1ra), has been shown to compete with the binding of IL-1 to its surface receptors. Thus, significant interest has arisen in administering IL-1ra to block the activity of IL-1 in various diseases including septic shock (Ohlsson et al. (1990)
Nature
348:550-556), immune complex-induced colitis (Cominelli (1990)
J. Clin. Invest
. 86:972-979), acute myelogenous leukemia (Rambaldi et al. (1990)
Blood
76:114-120) and osteoporosis (Pacifici et al. (1993)
J. Clin. Endocrinol. Metab
. 77:1135-1141).
SUMMARY OF THE INVENTION
The present invention is based, at least in part, on the discovery of novel IL-1 receptor antagonist (IL-1ra) -like molecules, referred to herein as SPOIL-1 nucleic acid and protein molecules. The SPOIL-1 molecules of the present invention are useful as modulating agents in regulating a variety of cellular processes. Accordingly, in one aspect, this invention provides isolated nucleic acid molecules encoding SPOIL-1 proteins and biologically active portions thereof, as well as nucleic acid fragments suitable as primers or hybridization probes for the detection of SPOIL-1-encoding nucleic acids.
In one embodiment, a SPOIL-1 nucleic acid molecule is 65% homologous to the nucleotide sequence shown in SEQ ID NO:3, SEQ ID NO:4, or a complement thereof In a preferred embodiment, an isolated SPOIL-1 nucleic acid molecule encodes the amino acid sequence of murine SPOIL-1.
In another embodiment, a SPOIL-1 nucleic acid molecule further comprises nucleotides 135-431 of SEQ ID NO:1. In yet another preferred embodiment, a SPOIL-1 nucleic acid molecule further comprises nucleotides 186-431 of SEQ ID NO:1.
In yet another preferred embodiment, an isolated SPOIL-1 nucleic acid molecule has the nucleotide sequence shown SEQ ID NO:3 or SEQ ID NO:4.
In another embodiment, a SPOIL-1 nucleic acid molecule includes a nucleotide sequence encoding a protein having an amino acid sequence sufficiently homologous to the amino acid sequence of SEQ ID NO:2 or SEQ ID NO:5. In yet another embodiment, a SPOIL-1 nucleic acid molecule includes a nucleotide sequence encoding a protein having an amino acid sequence at least 60% homologous to the amino acid sequence of SEQ ID NO:2 or SEQ ID NO:5. In a preferred embodiment, a SPOIL-1 nucleic acid molecule includes a nucleotide sequence encoding a protein having the amino acid sequence of SEQ ID NO:2 or SEQ ID NO:5.
In another embodiment, an isolated nucleic acid molecule of the present invention encodes a SPOIL-1 protein which includes an interleukin-1 (IL-1) signature domain, optionally, a signal sequence and is secreted. In another embodiment, an isolated nucleic acid molecule of the present invention encodes a SPOIL-1 protein which includes an IL-1 signature domain and has SPOIL-1 biological activity. The SPOIL-1 nucleic acid molecule can also encode a SPOIL-1 protein and is a naturally occurring nucleotide sequence. In yet another embodiment, an isolated nucleic acid molecule of the present invention encodes a SPOIL-1 protein and comprises a nucleotide sequence which hybridizes under stringent hybridization conditions to a nucleic acid molecule having the nucleotide sequence of SEQ ID NO:3 or SEQ ID NO:4.
In another embodiment, the SPOIL-1 nucleic acid molecule is at least 500 nucleotides in length and hybridizes under stringent conditions to a nucleic acid molecule comprising the nucleotide sequence shown in SEQ ID NO:3, SEQ ID NO:4, or a complement thereof
Another embodiment the invention provides an isolated nucleic acid molecule which is antisense to the coding strand of a SPOIL-1 nucleic acid.
Another aspect of the invention provides a vector comprising a SPOIL-1 nucleic acid molecule. In certain embodiments, the vector is a recombinant expression vector. In a preferred embodiment, the vector comprises the SPOIL-1 nucleic acid sequence of SEQ ID NO:3 or SEQ ID NO:4. In another embodiment, the invention provides a host cell containing a vector of the invention. The invention also provides a method for producing SPOIL-1 protein by culturing in a suitable medium, a host cell of the invention containing a recombinant expression vector such that SPOIL-1 protein is produced.
Another aspect of this invention features isolated or recombinant SPOIL-1 proteins and polypeptides. In one embodiment, an isolated SPOIL-1 protein has an IL-1 signature domain, optionally, a signal sequence, and is secreted. In another embodiment, an isolated SPOIL-1 protein has an IL-1 signature domain and a SPOIL-1 biological activity. In yet another embodiment, an isolated SPOIL-1 protein has an amino acid sequence sufficiently homologous to the amino acid sequence of SEQ ID NO:2 or SEQ ID NO:5. In a preferred embodiment, a SPOIL-1 protein has an amino acid sequence at least about 60% homologous to the amino acid sequence of SEQ ID NO:2 or SEQ ID NO:5. In another embodiment, a SPOIL-1 protein has the amino acid sequence of SEQ ID NO:2 or SEQ ID NO:5.
Another embodiment of the invention features an isolated SPOIL-1 protein which is encoded by a nucleic acid molecule having a nucleotide sequence at least about 65% homologous to a nucleotide sequence of SEQ ID NO:3, SEQ ID NO:4, or a complement thereof. This invention also features an isolated SPOIL-1 protein which is encoded by a nucleic acid molecule having a nucleotide sequence which hybridizes under stringent hybridization conditions to a nucleic acid molecule comprising the nucleotide sequence of SEQ ID NO:3, SEQ ID NO:4, or a complement thereof.
The SPOIL-1 proteins of the present invention, or biologically active portions thereof, can be operatively linked to a non-SPOIL-1 polypeptide to form SPOIL-1 fusion proteins. The invention further features antibodies that specifically bind SPOIL-1 proteins, such as monoclonal or polyclonal antibodies. In addition, the SPOIL-1 proteins or biologically active portions thereof can be incorporated into pharmaceutical compositions, which optionally include pharmaceutically acceptable carriers.
In another aspect, the present invention provides a method for detecting SPOIL-1 expression in a biological sample by contacting the biological sample with an agent capable of detecting a SPOIL-1 nucleic acid molecule, protein or polypeptide such that the pre

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Spoil-1 protein and nucleic acid molecules and uses therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Spoil-1 protein and nucleic acid molecules and uses therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spoil-1 protein and nucleic acid molecules and uses therefor will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2497601

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.